Government bodies, biobanks and non-profits at FoG London 2027

Jan 27–28, 2027 London, UK ~8.3k attendees Website

33 government bodies, biobanks and non-profits are at FoG London 2027 — 41 presentations on the program and 13 with a booth in the exhibit hall. Most represented: Our Future Health (5 on the program), Genomics England (4 on the program), NIHR BioResource (3 on the program). 21 of them have their own page in this guide. As of Oct 29, 2026.

All 243 organizations at FoG London 2027 →

Topic
Top represented
Showing 1–12 of 33 organizations
OrganizationFoG London 2027 Attendance
Government & non-profit
UK health research programme recruiting millions of adult volunteers who share health data and blood samples to study prevention and early detection.
Booth
Exhibiting at Booth 106B
Panel
Wed Jan 27
10:20–11:00
The UK's Health Data Advantage: Powering the Future of Life Sciences
What makes the UK's national genomic and health datasets valuable, and where they and AI could advance disease research and drug discovery.
with Genomics England, UK Biobank, NIHR BioResource +1 more
Biodata & bioinformatics
Talk
Wed Jan 27
14:30–15:00
Building the UK’s Health Data Ecosystem: What’s Next for Our National Genomic & Population Resources?
Plans for the UK's major genomic and health data resources, and how to link them while protecting privacy and public trust.
with Genomics England, UK Biobank, NIHR BioResource
Talk
Wed Jan 27
14:30–15:00
From Risk Prediction to Precision Prevention
How large population cohorts let researchers study disease risk before symptoms appear, to find biomarkers and build evidence for prevention.
Talk
Wed Jan 27
14:30–16:00
Trust in the Data Age: Who Should Access Our Genomic Data and Why?
Genome Dome · with NIHR BioResource
Biodata & bioinformaticsPopulation & social genomics
Talk
Thu Jan 28
12:00–12:30
Finding The Right Participants For The Right Research
How matching people by clinical, genetic or risk profile to suitable studies could speed recruitment for precision clinical research.
Government & non-profit
Government-owned company providing whole-genome sequencing for the NHS Genomic Medicine Service and research, including the Generation newborn study.
Panel
Wed Jan 27
10:20–11:00
The UK's Health Data Advantage: Powering the Future of Life Sciences
What makes the UK's national genomic and health datasets valuable, and where they and AI could advance disease research and drug discovery.
with Our Future Health, UK Biobank, NIHR BioResource +1 more
Biodata & bioinformatics
Talk
Wed Jan 27
14:30–15:00
Building the UK’s Health Data Ecosystem: What’s Next for Our National Genomic & Population Resources?
Plans for the UK's major genomic and health data resources, and how to link them while protecting privacy and public trust.
with Our Future Health, UK Biobank, NIHR BioResource
Talk
Wed Jan 27
14:30–15:00
The Generation Study: Insights From a National Study of Newborn Genome Sequencing
What a national study sequencing newborn genomes has learned so far about recruitment and results, and what it means for newborn screening.
Talk
Thu Jan 28
14:40–15:10
The Genomics England Adult Population Programme
How Genomics England is designing a genomics programme for the adult population, what public engagement has taught, and its future plans.
NIHR BioResource
Cambridge, UK
Government & non-profit
National panel of volunteers, with and without health conditions, who give samples and data and can be recalled for research studies.
Booth
Exhibiting at Booth 108
Panel
Wed Jan 27
10:20–11:00
The UK's Health Data Advantage: Powering the Future of Life Sciences
What makes the UK's national genomic and health datasets valuable, and where they and AI could advance disease research and drug discovery.
with Our Future Health, Genomics England, UK Biobank +1 more
Biodata & bioinformatics
Talk
Wed Jan 27
12:30–13:00
What We've Been Missing: Unlocking New Discoveries Through Large-Scale Long-Read Sequencing
How large-scale long-read sequencing, which reads long DNA stretches, uncovers hidden genome regions, with early findings in mental health and rare disease.
Genomic medicine & rare disease
Talk
Wed Jan 27
14:30–15:00
Building the UK’s Health Data Ecosystem: What’s Next for Our National Genomic & Population Resources?
Plans for the UK's major genomic and health data resources, and how to link them while protecting privacy and public trust.
with Genomics England, Our Future Health, UK Biobank
Talk
Wed Jan 27
14:30–16:00
Trust in the Data Age: Who Should Access Our Genomic Data and Why?
Genome Dome · with Our Future Health
Biodata & bioinformaticsPopulation & social genomics
Government & non-profit
National body leading the NHS in England, including the NHS Genomic Medicine Service and national genomic testing.
Talk
Wed Jan 27
09:00–09:30
The Next Chapter of Genomic Medicine
How genomics is being built into everyday care nationally, and the staff, systems and partnerships it will take to scale up.
Genomic medicine & rare disease
Talk
Wed Jan 27
16:30–17:00
NHS Genomics Data & Digital: Progress Towards a More Connected Genomic Medicine Service
What the NHS genomics data programme changed this past year, from test ordering to moving genomic results between services, and what comes next.
Talk
Wed Jan 27
17:00–17:30
One Patient, One Genomic Record: Making Genomics Work Across the NHS
How the NHS plans to record each patient's genomic results once and share them with clinicians, using data from 26 genomic laboratories.
Talk
Thu Jan 28
16:10–17:10
UK Healthcare Updates
Main Stage · with Scottish Pandemic Sciences Partnership, NHS Greater Glasgow and Clyde, Welsh Government
Genomic medicine & rare disease
UK Biobank
Stockport, UK
Government & non-profit
Research resource holding genetic, proteomic, imaging and health record data from 500,000 UK volunteers for approved researchers worldwide.
Panel
Wed Jan 27
10:20–11:00
The UK's Health Data Advantage: Powering the Future of Life Sciences
What makes the UK's national genomic and health datasets valuable, and where they and AI could advance disease research and drug discovery.
with Our Future Health, Genomics England, NIHR BioResource +1 more
Biodata & bioinformatics
Talk
Wed Jan 27
11:30–12:00
UK Biobank: Unlocking the Power of Population-Scale Data for Science and Health
Biodata Stage
Talk
Wed Jan 27
14:30–15:00
Building the UK’s Health Data Ecosystem: What’s Next for Our National Genomic & Population Resources?
Plans for the UK's major genomic and health data resources, and how to link them while protecting privacy and public trust.
with Genomics England, Our Future Health, NIHR BioResource
Talk
Wed Jan 27
15:30–16:00
Population Proteomics at Scale: How UK Biobank Is Transforming Drug Discovery and Precision Medicine
How measuring proteins across the UK Biobank population, combined with genetic and clinical data, helps uncover biomarkers and new drug targets.
Also
Presenting at the meeting, beyond the sessions above
Government & non-profit
UK national institute for health data science; leads programmes such as DARE UK on secure, federated access to health data.
Talk
Wed Jan 27
15:30–16:00
Streamlining and Accelerating Health Data Discovery and Access
How UK services help researchers find and request health data, vet who may use it, and build shared tools once for reuse.
Talk
Wed Jan 27
17:30–18:00
Enhancing TRE Capabilities to Support Federation and AI Projects: the Experience of DARE UK
How the UK's more than 60 secure research environments, where sensitive data never leaves, could be linked up and support AI projects safely.
M
MHRA
London, UK
Government & non-profit
UK regulator of medicines and medical devices, including clinical trial and marketing approvals for advanced therapies.
Talk
Thu Jan 28
14:10–14:40
De-risking ATMP Innovation & Streamlining Pathways to Deliver Better Outcomes for Patients
How advanced cell and gene therapies could reach patients sooner through smarter trials, a new law allowing on-site manufacturing, and fairer research.
Talk
Thu Jan 28
16:40–17:10
Navigating MHRA Guidelines and Clinical Trial Regulations for ATMPs
How to apply to the UK medicines regulator for a clinical trial of an advanced cell or gene therapy, with practical tips.
Government & non-profit
National public health agency for Wales, running screening programmes, including newborn screening, and health protection services.
Talk
Wed Jan 27
15:00–15:30
A Multi-Omic and Ethical Framework for Newborn Screening in Wales
How Wales pairs metabolic tests with genomics in newborn screening, puts each baby's benefit first, and tests genome sequencing from dried blood spots.
Talk
Thu Jan 28
12:30–13:00
Could Polygenic Risk Scores Transform Preventive Health in Wales?
Whether polygenic risk scores, which combine many small genetic effects, could add to NHS health checks in Wales to spot hidden disease risk.
Government & non-profit
NHS Wales body advising on access to medicines, their safe and effective use, and poisons information.
Talk
Thu Jan 28
11:30–12:00
Building System Readiness for Disruptive Medicines in Wales
How Wales is preparing its health service for new precision medicines, planning 6–12 months before national approval guidance to meet a 60-day access target.
ELIXIR
Hinxton, UK
Government & non-profit
Intergovernmental organisation coordinating life science data resources and infrastructure across European countries, including federated human genomics data.
Talk
Wed Jan 27
12:30–13:00
Building Europe’s Federated Genomics Infrastructure: From Technical Foundations to Data at Scale
How European projects are linking national genomic data services so researchers can securely find and analyse sensitive data across countries.
with Queen's University Belfast
Government & non-profit
UK national service, backed by government and Wellcome, set up to give researchers a single route to NHS health data.
Talk
Wed Jan 27
10:00–10:20
Unlocking the UK's Health Data Potential: The Vision and Future of HDRS
What the UK's national health data research service learned in its first year, and how it plans to simplify health data research.
Biodata & bioinformatics
Panel
Wed Jan 27
10:20–11:00
The UK's Health Data Advantage: Powering the Future of Life Sciences
What makes the UK's national genomic and health datasets valuable, and where they and AI could advance disease research and drug discovery.
with Our Future Health, Genomics England, UK Biobank +1 more
Biodata & bioinformatics
Government & non-profit
Independent UK innovation and technology organisation supporting the development, manufacture and adoption of cell and gene therapies.
Booth
Exhibiting at Booth 15
Talk
Thu Jan 28
12:30–13:00
The Acceleration of Therapies from Diagnosis to Delivery
How genomic diagnosis is opening the way to personalised treatments, and what UK treatment centres have learned about getting advanced therapies to patients.

Explore the full FoG London 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full FoG London 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from government bodies, biobanks and non-profits

Tell us what you sell and we’ll find the people at these government bodies, biobanks and non-profits most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse FoG London 2027 by

Exhibit hall

Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction